Press Release

Aleafia Health Launches Portfolio of Exclusive Cultivars

  • Highly sought-after strain Wedding Cake available today
  • BLLRDR is majority-owned by two-time GRAMMY Award winning producer Noah “40” Shebib and original Emblem co-founder Max Zavet
  • Additional near-term expansion of product portfolio with launch of new cannabis 2.0 formats and dried flower in Q1 2021
  • Product launches key accelerator in driving record revenue in Q4 2020

TORONTO, January 12, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its portfolio of exclusive cannabis cultivars with highly sought-after strain Wedding Cake. In the Canadian medical cannabis market, it is exclusively available through Emblem Cannabis Corporation, a wholly-owned subsidiary of Aleafia Health.

Wedding Cake is licensed through a supply agreement with cannabis brand house Robes Cannabis Inc. (dba BLLRDR). GRAMMY Award winning producer and OVO co-founder, Noah “40” Shebib, and Emblem co-founder Max Zavet are BLLRDR’s majority owners.

The launch is part of a broader expansion of the Company’s portfolio of unique cannabis cultivars which will see further strains to enter the adult-use and medical cannabis markets this year.

“The introduction of new products continues to be our most important accelerator in driving further growth in the Canadian market. Today’s launch allows us to strengthen our unique medical patient experience, featuring differentiated formats, physician-led cannabinoid therapy, and same-day delivery,” said Aleafia Health CEO Geoffrey Benic. “We look forward to delivering on further innovative product launches this quarter and throughout 2021.”

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Innovation, the heart of Aleafia Health’s competitive advantage, has led to the Company maintaining a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value; the TSX Venture Exchange named Aleafia the 2019 top performing company prior to its graduation to the TSX.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Get the latest Aleafia Health investor updates - subscribe now

Get the latest Aleafia Health investor updates - subscribe now

By subscribing, I accept the Terms of Service & Privacy Policy, and I understand I can unsubscribe at any time.